Category: Medical Cannabis News

They write, “The country saw 568 medical cannabis approvals in November, a 42% increase on-month, bringing the total number of approvals for the first 11 months of 2018 to 2,072, according to the Therapeutic Goods Administration (TGA), which regulates medical marijuana in Australia.”

The Cannabis Access Clinic in Subiaco aims to streamline the access to medicinal cannabis with health professionals proficient in the area.Reports WA Today.

Leaders from the medicinal cannabis industry met in Adelaide this past week to discuss the future of the drug in Australia.

“I cannot see a logic in restricting prescriptions to hospital consultants, which narrows the pool of expertise, particularly in Jersey.

109 to be exact.

The Colorado Department of Public Health and Environment has awarded $2.7 million in grant funding for two research studies to investigate the potential therapeutic uses of marijuana.

 Both research studies are random controlled trials, the type of research considered to be the “gold standard” in the scientific community. One study will research marijuana as a treatment for chronic spine pain and will evaluate its use as a therapy to reduce prescription opioid use. The other will research the efficacy and safety of cannabidiol (CBD) to treat children with autism spectrum disorder.

Israeli business publication, Globes, writes, “With the aid of a survey by Cann10 of the Shizim group, in collaboration with Deloitte and crowdfunding platform OurCrowd carried out in advance of an international conference held two weeks ago, “Globes” presents here the areas of activity and the outstanding companies in the cannabis industry, and analyzes the forces at work in the market.”

The BMJ reports….. The parents of severely epileptic children have launched a campaign to try to get the strict new guidelines for the provision of medicinal cannabis revised after some found that doctors were reluctant to prescribe the recently legalised medication.

All the state’s major physician groups—including the Kansas City Medical Society, of which Mammen is president—opposed every marijuana measure on the ballot. Reports Medical Xpress.com.

To alleviate suffering for thousands of Texas patients, Senator Jose Menendez filed Senate Bill 90, a comprehensive and compassionate medical cannabis bill. If passed, Texas would become the 33rd state to offer medical cannabis for qualifying patients. The proposed legislation would increase the number of debilitating medical conditions that qualify for the Texas Compassionate Use Program (T.CUP). Senate Bill 90 would also allow doctors to treat medical cannabis like any other medicine.

It became legal for doctors to prescribe cannabis based drugs on 1 November. But who will be able to issue these products, for what conditions, and what’s the evidence? Nigel Hawkes reports

Canopy hope the UK Home office is paying attention to its press releases ! “Spectrum Cannabis, a wholly-owned subsidiary of Canopy Growth Corporation (TSX: WEED)(NYSE: CGC), joins UK patients, researchers and clinicians in applauding today’s first prescriptions of medicinal cannabis. From today, patients with exceptional clinical need in England, Wales and Scotland will be prescribed cannabis-based medicines by specialist clinicians for the first time.”

Fortune reminds us that GW Pharma now allowed to sell Epidiolex USA wide. This should improve share activity

Leafly reports.. It’s apparently taken a while for word of the move to get to the US. Javier Hesse, a staff writer at the financial website Benzinga who reported the news on Monday, quotes an official government document that suggests the legal change began more than a month ago:

The Department of of Health has announced that Rhode Island families can now access medical marijuana to treat autism. The decision was issued this week after a petition was filed in April to add autism spectrum disorder (ASD) to the list of qualifying conditions for medical marijuana.

The American Medical Marijuana Physicians Association announces its second annual conference will take place Oct. 12-14 at the Hilton Orlando Lake Buena Vista. The AMMPA Annual Conference is one of the largest conferences in the nation dedicated to physician education and the utilization of medical cannabis as an alternative treatment option.